serine and metoprolol

serine has been researched along with metoprolol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ijzerman, AP; Krasel, C; Lohse, MJ; Wieland, K; Zuurmond, HM1
Blackburn, MG; Ellis, SW; Harlow, J; Hayhurst, GP; Larsson, C; Lennard, MS; Lightfoot, T; Lim, CK; Mahling, J; Rowland-Yeo, K; Smith, G; Tucker, GT; Wolf, CR1
Chen, SR; Davidoff, AW; Mei, J; Obayashi, M; Stuyvers, BD; ter Keurs, HE; Xiao, B1
Bloch, W; Brixius, K; Hoyer, H; Ladage, D; Malan, D; Schwinger, RH; Steingen, C; Wesseling, A1

Other Studies

4 other study(ies) available for serine and metoprolol

ArticleYear
Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Aug-20, Volume: 93, Issue:17

    Topics: Adenylyl Cyclases; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Alprenolol; Animals; Asparagine; Binding Sites; CHO Cells; Computer Simulation; Cricetinae; Humans; Isoproterenol; Metoprolol; Models, Molecular; Mutagenesis, Site-Directed; Mutation; Propranolol; Receptors, Adrenergic, beta-2; Serine; Signal Transduction; Stereoisomerism

1996
Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6.
    The Biochemical journal, 2000, Feb-01, Volume: 345 Pt 3

    Topics: Alanine; Amino Acid Substitution; Aspartic Acid; Binding Sites; Catalytic Domain; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Debrisoquin; Enzyme Inhibitors; Kinetics; Ligands; Metoprolol; Mutagenesis, Site-Directed; Oxidation-Reduction; Propranolol; Quinidine; Quinine; Serine; Substrate Specificity; Yeasts

2000
Spontaneous diastolic contractions and phosphorylation of the cardiac ryanodine receptor at serine-2808 in congestive heart failure in rat.
    Cardiovascular research, 2006, Volume: 69, Issue:1

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Diastole; Echocardiography; Heart Failure; Isoproterenol; Male; Metoprolol; Models, Animal; Myocardial Contraction; Phosphorylation; Rats; Rats, Inbred BN; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Serine; Tacrolimus

2006
Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells.
    Clinical and experimental pharmacology & physiology, 2006, Volume: 33, Issue:8

    Topics: Adrenergic beta-Antagonists; Benzopyrans; Cells, Cultured; Endothelial Cells; Enzyme Activation; Estradiol; Estrogen Receptor Modulators; Ethanolamines; Fluorescein; Fulvestrant; Humans; Immunohistochemistry; Indicators and Reagents; Metoprolol; Microscopy, Fluorescence; Nebivolol; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Propanolamines; Protein Transport; Receptors, Adrenergic, beta-3; Receptors, Estrogen; Serine; Time Factors; Umbilical Veins; Vasodilator Agents

2006